• Publications
  • Influence
Two isoforms of tissue transglutaminase mediate opposing cellular fates
Opposing cellular responses are typically regulated by distinct sets of genes. However, tissue transglutaminase (TGase) provides an interesting example of a single gene product that has beenExpand
  • 86
  • 5
  • PDF
Augmentation of Tissue Transglutaminase Expression and Activation by Epidermal Growth Factor Inhibit Doxorubicin-induced Apoptosis in Human Breast Cancer Cells*
Tissue transglutaminase (TGase) exhibits both a GTP binding/hydrolytic capability and an enzymatic transamidation activity. Increases in TGase expression and activation often occur in response toExpand
  • 114
  • 3
  • PDF
A dopamine transporter polymorphism is a risk factor for borderline personality disorder in depressed patients.
BACKGROUND Borderline personality disorder (BPD) is often co-morbid with major depression and may complicate its treatment. We were interested in differences in genetic and developmental risk factorsExpand
  • 56
  • 1
Provider and pharmacist responses to warfarin drug-drug interaction alerts: a study of healthcare downstream of CPOE alerts
OBJECTIVE To categorize the appropriateness of provider and pharmacist responses to warfarin critical drug-drug interaction (cDDI) alerts, assess responses and actions to the cDDI, and determine theExpand
  • 36
  • PDF
Chronic myelogenous leukemia and porphyria cutanea tarda in a patient with limited systemic sclerosis.
Systemic sclerosis is uncommonly associated with hematologic malignancies. We report the case of a patient who had chronic myelogenous leukemia 3 years after the CREST variant of systemic sclerosisExpand
  • 15
Current technologies to endotoxin detection and removal for biopharmaceutical purification
Endotoxins are the major contributors to the pyrogenic response caused by contaminated pharmaceutical products, formulation ingredients, and medical devices. Recombinant biopharmaceutical productsExpand
  • 3
Racial disparities in hypertension control: not the provider but still a problem.
To the Editor: We read with interest the Umscheid et al. article entitled “Racial Disparities in Hypertension Control, but Not Treatment Intensification,” which looked at the likelihood ofExpand
  • 1